diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance prevents glucose uptake by cells, leading to hyperglycemia. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells results in little or no insulin production. In Type 2 diabetes, cells become resistant to insulin, and the pancreas cannot produce enough insulin to overcome this resistance.

• Secondary mechanism: Chronic hyperglycemia causes damage to blood vessels and nerves. This damage results from the formation of advanced glycation end-products and oxidative stress, leading to inflammation and vascular complications.

• Key complication: Persistent high blood sugar levels can lead to diabetic complications such as neuropathy, nephropathy, and retinopathy, which are significant concerns in nursing care and patient education.

Patient Profile

Demographics:

52-year-old female, administrative assistant

History:

• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 40 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and tingling in feet

• Key symptoms: Blurred vision, frequent urination, excessive thirst, unexplained weight loss, numbness in extremities

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 210 mg/dL

Section 1

After performing an initial assessment, the nurse notes that the patient's feet exhibit signs of peripheral neuropathy, characterized by diminished tactile sensation and impaired vibratory sense. The patient also reports experiencing sharp, shooting pains intermittently in her lower extremities, particularly at night. Physical examination reveals diminished pedal pulses, and her capillary refill time in the toes is slightly delayed. These findings suggest peripheral vascular disease, a common complication of diabetes that can exacerbate neuropathic symptoms and increase the risk of foot ulcers and infections.

The nurse orders a comprehensive metabolic panel and a hemoglobin A1c test to evaluate the patient's glycemic control over the past three months. The hemoglobin A1c result returns at 9.2%, indicating suboptimal blood sugar management. Furthermore, the patient's lipid profile reveals elevated LDL cholesterol at 145 mg/dL, despite being on atorvastatin. These results suggest that her current therapeutic regimen might need adjustments to better manage her diabetes and associated risks.

Recognizing the potential for progression of complications, the healthcare team decides to implement a more aggressive diabetes management plan. This includes a referral to a diabetes educator for lifestyle modification and dietary counseling, consideration of adding a glucagon-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control, and a consultation with a podiatrist to prevent potential foot complications. With these interventions, the team aims to mitigate the progression of diabetic complications and improve the patient's quality of life.

Section 2

Two weeks after the implementation of the revised diabetes management plan, the patient returns for a follow-up appointment. During this visit, the nurse conducts a thorough reassessment. The patient reports an improvement in her energy levels and a slight reduction in the frequency of night-time leg pain. However, she admits to occasional difficulty adhering to the recommended dietary changes, particularly in managing portion sizes. The physical examination reveals stable vital signs with a blood pressure of 138/86 mmHg and heart rate of 78 beats per minute. Her weight has decreased by 2 pounds since the last visit, indicating positive lifestyle changes.

Upon reviewing new laboratory results, the nurse notes a slight improvement in the patient's glycemic control, with a hemoglobin A1c now at 8.7%. Although still above the target range, this reduction suggests a positive response to the intensified management plan. The patient's lipid profile has also shown modest improvement, with LDL cholesterol reduced to 130 mg/dL. These results indicate that while progress is being made, further adjustments in her medication regimen may be necessary to achieve optimal targets.

Despite these improvements, the patient reports new symptoms of intermittent claudication, characterized by cramping pain in her calves during walking, which subsides with rest. This suggests a potential progression of her peripheral vascular disease. The nurse collaborates with the healthcare team to reassess the patient's cardiovascular risk factors and consider additional interventions, such as an antiplatelet agent, to address her vascular health. Continued close monitoring of her foot health is emphasized to prevent ulceration, and the importance of adhering to her modified treatment plan is reinforced. This ongoing evaluation will play a critical role in refining her management strategy and preventing further complications.

Section 3

During the follow-up visit, the nurse notes that the patient’s intermittent claudication has become more pronounced, now occurring after shorter distances of walking. Concerned about this change, the healthcare team decides to perform a Doppler ultrasound to evaluate the blood flow in her lower extremities. The results reveal significant stenosis in the femoral arteries, consistent with peripheral artery disease (PAD). This finding indicates a worsening condition that requires immediate attention to prevent complications such as critical limb ischemia or ulcer formation.

In response to these diagnostic results, the healthcare team discusses the introduction of cilostazol, a medication aimed at improving walking distance and reducing claudication symptoms. Additionally, the team emphasizes the importance of smoking cessation, as the patient has a history of smoking, which is a major risk factor for PAD progression. The nurse educates the patient on lifestyle modifications, including the importance of adhering to a structured walking program that alternates activity with rest. The patient's blood pressure, although stable, is still above the ideal range for someone with diabetes and PAD, prompting consideration of adjusting her antihypertensive therapy to better manage her cardiovascular risk.

This change in patient status underscores the need for a multidisciplinary approach, involving cardiologists and vascular specialists, to optimize her care plan. The nurse ensures that the patient is aware of the signs of worsening PAD and stresses the importance of timely follow-up appointments. By addressing these new complications and refining her management strategy, the team aims to stabilize her condition and prevent further vascular deterioration, setting the stage for the next phase of her diabetes management journey.

Section 4

As the patient returns for a follow-up appointment after the initiation of cilostazol and lifestyle modifications, the nurse conducts a thorough assessment to evaluate the effectiveness of the interventions and identify any new complications. The patient reports a modest improvement in her claudication symptoms, noting that she can now walk slightly longer distances before experiencing discomfort. However, during the assessment, the nurse observes that the patient’s left foot appears slightly cooler to the touch compared to previous visits, and the skin on her toes has developed a bluish hue, raising concerns about potential critical limb ischemia.

To further investigate these findings, the healthcare team orders an ankle-brachial index (ABI) test to assess the severity of blood flow restriction in the lower extremities. The results indicate a significant drop in the ABI value on the left side, confirming worsening ischemia. Additionally, the patient’s blood pressure readings have risen to 160/95 mmHg, suggesting that her current antihypertensive regimen may require adjustment. Laboratory tests reveal an elevated hemoglobin A1c level of 8.5%, indicating suboptimal glycemic control, which may be contributing to the progression of her vascular disease.

In response to these new complications, the healthcare team decides to adjust the patient's antihypertensive therapy by adding an ACE inhibitor to address the elevated blood pressure and provide renal protection, which is crucial in diabetes management. The team also emphasizes the urgent need to achieve better glycemic control, recommending a consultation with an endocrinologist to optimize her diabetes treatment plan. Recognizing the potential for critical limb ischemia, a vascular surgery consultation is expedited to explore potential revascularization options. The nurse reinforces the importance of monitoring for signs of worsening ischemia, such as increased pain or skin changes, and ensures that the patient understands the significance of adhering to her medication regimen and lifestyle modifications to stabilize her condition and prevent further complications.

Section 5

As the patient continues her treatment plan, she returns for another follow-up appointment after the initiation of the ACE inhibitor and a consultation with the endocrinologist. During this visit, the nurse conducts a detailed assessment to evaluate the patient's response to the new interventions. The patient reports a slight decrease in her blood pressure readings at home, averaging around 145/90 mmHg, which, while improved, still indicates the need for closer management. The patient also mentions adherence to the adjusted diabetes regimen, which now includes a basal-bolus insulin approach, and expresses optimism about her ability to manage her blood glucose levels more effectively.

However, the nurse notes that the patient’s left foot remains cool to the touch with a persistent bluish discoloration of the toes. The patient reports occasional numbness and tingling in her left foot, especially after periods of prolonged activity. These symptoms, combined with the patient's elevated hemoglobin A1c level, suggest potential progression of peripheral neuropathy, a common complication in diabetes. Furthermore, the nurse observes that the patient has developed a small, non-healing ulcer on the lateral aspect of her left foot, raising concerns about the increased risk of infection and further ischemic damage.

In light of the new findings, the healthcare team prioritizes the management of the foot ulcer and emphasizes the importance of preventing infection. A wound care specialist is consulted to develop a comprehensive care plan, including proper debridement, dressing changes, and possible antibiotic therapy. The nurse educates the patient on meticulous foot care practices and the importance of ongoing monitoring for any changes in skin integrity. The team also revisits the possibility of revascularization, as the vascular surgery consultation remains a critical step in addressing the patient's ischemia and preventing limb loss. By addressing these emerging complications, the healthcare team aims to stabilize the patient's condition and improve her overall quality of life.